The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The SNP Genotyping And Analysis Market Increase Between 2026 And 2030?
The snp genotyping and analysis market size has seen exponential expansion in recent years. It is projected to increase from $18.5 billion in 2025 to $22.24 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 20.2%. The growth observed in the historic period can be ascribed to factors including the declining cost of genetic testing, expansion of academic genomics research, growth in disease diagnostics, pharmaceutical r&d investment, and the development of microarray technologies.
The snp genotyping and analysis market is projected to experience substantial growth in the upcoming years. It is anticipated to reach $46.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 20.1%. This growth during the forecast period stems from factors such as the expansion of personalized medicine, a rise in the utilization of companion diagnostics, AI-driven genomic analytics, the broadening of clinical genomics, and various government genomics initiatives. Key trends observed within the forecast timeframe encompass the wider application of precision medicine, increasing acceptance of pharmacogenomics, enhanced reliance on cfdna and liquid biopsy, the proliferation of high-throughput genotyping platforms, and the incorporation of AI into genetic data analysis.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24402&type=smp
Which Growth Factors Are Strengthening The SNP Genotyping And Analysis Market Landscape?
The increasing prevalence of genetic diseases is anticipated to boost the expansion of the SNP genotyping and analysis market. These conditions are defined as disorders stemming from abnormalities in an individual’s DNA, which may be inherited from parents or arise from mutations during cell division. The escalating burden of genetic diseases is attributed to heightened awareness and advancements in diagnostic technologies, resulting in more diagnoses and a clearer recognition of genetic disorders. SNP genotyping and analysis aid in addressing genetic diseases by identifying genetic variations associated with disease risk, progression, and drug response, thereby enabling early diagnosis and personalized treatment. For instance, in February 2023, the World Health Organization, an international public health agency based in Switzerland, estimated that congenital disorders caused around 240,000 newborn deaths worldwide within the first 28 days of life each year, in addition to 170,000 deaths among children aged 1 month to 5 years. Consequently, the rising burden of genetic diseases is a significant driver for the growth of the SNP genotyping and analysis market.
How Are Different Segment Groups Identified Within The SNP Genotyping And Analysis Market?
The snp genotyping and analysis market covered in this report is segmented –
1) By Sample Type: Genomic DNA, Ribonucleic Acid (RNA), Cell-Free DNA (cfDNA), Plasma Samples, Whole Blood
2) By Technology: Microarrays And GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequemon MassArray Maldi-TOF, Other Technologies
3) By Application: Disease Diagnostics, Pharmacogenomics, Precision Medicine, Forensic Science, Agriculture And Livestock
4) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical And Biotechnological Companies, Diagnostic Laboratories, Academic And Government Institutions
Subsegments:
1) By Genomic DNA: Whole Genome Sequencing (WGS), Targeted Sequencing, Microarrays
2) By Ribonucleic Acid (RNA): RNA-Seq, Expression Profiling, Microarrays
3) By Cell-Free DNA (cfDNA): Liquid Biopsy, Non-Invasive Prenatal Testing (NIPT), Oncology Research
4) By Plasma Samples: Circulating Tumor DNA (ctDNA), Liquid Biopsy Applications, Diagnostics
5) By Whole Blood: DNA Extraction And Analysis, Blood-Based Genomic Studies, Genotyping And Molecular Diagnostics
Which Trends Are Guiding The Development Of The SNP Genotyping And Analysis Market?
Leading companies within the SNP genotyping and analysis market are dedicating efforts to devising innovative solutions, such as agricultural large-scale low-pass whole genome sequencing, aimed at resolving critical difficulties in molecular breeding genotyping of agricultural diploid species. Agricultural whole genome sequencing involves decoding the complete genetic blueprint of crops or livestock to enhance desirable characteristics like yield, disease immunity, and environmental resilience. As an illustration, in June 2024, MGI Tech, a China-based biotechnology company, unveiled a highly efficient end-to-end workflow solution tailored for agricultural large-scale low-pass whole genome sequencing (low-pass WGS). This offering encompasses an automated, comprehensive product suite covering DNA extraction, library preparation, sequencing, and SNP & InDel calling, specifically crafted for molecular breeding genotyping of agricultural diploid species. It integrates sophisticated automation platforms and employs MGI’s DNBSEQ-T7 and DNBSEQ-G400 sequencers to ensure exceptional throughput and versatility. The workflow also incorporates pig reference panels and data analysis software to streamline genotyping processes without requiring the development of bespoke databases.
Who Are The Businesses Driving Activity In The SNP Genotyping And Analysis Market?
Major companies operating in the snp genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International
Access The Complete SNP Genotyping And Analysis Market Report:
https://www.thebusinessresearchcompany.com/report/snp-genotyping-and-analysis-global-market-report
Which Region Has The Strongest Presence In The SNP Genotyping And Analysis Market?
North America was the largest region in the SNP genotyping and analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the snp genotyping and analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access SNP Genotyping And Analysis Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24402&type=smp
Browse Through More Reports Similar to the Global SNP Genotyping And Analysis Market 2026, By The Business Research Company
Single Nucleotide Polymorphism Snp Genotyping Market Report 2026
Genotyping Market Report 2026
https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report
Genotyping Assay Market Report 2026
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model